Category: Hologic Inc.
Hologic hands former Stryker CEO Steven MacMillan the keys to the corner office, agrees to take on 2 new board members to pacify an activist investor and enlists a new scientific advisor.
Shareholders of Interlace Medical, which Hologic acquired in 2011, sue the women's health company for additional payouts of almost $15 million.
Hologic (NSDQ:HOLX) has already been through its fair share of legal action from its acquisition of Interlace Medical, which it acquired for $125 million in 2011.
Hologic braces against a possible hostile takeover as activist investor Carl Icahn acquires a hefty stake in the women's health company.
Massachusetts-based Hologic (NSDQ:HOLX) announced today that it adopted a stockholder rights plan, just as activist investor Carl Icahn nabbed up more than 12.6% of the company.
Women's health company Hologic posts Q4 and full-year earnings that beat Wall Street's expectations, but the company takes a $1.1 billion impairment charge that multiplies net losses.
Company officials at Hologic discuss the company's Q4 2013 earnings call. The company reported losses of $1.11 billion, or $4.11 per share, on sales of $622.1 million for the 3 months ended September 28, for loss growth of of 1332% on sales growth of 5.7%.
Hologic asks a federal judge to revisit its loss to rival Smith & Nephew over the MyoSure fibroid surgery device it acquired along with Interlace Medical.
Women's health company Hologic releases final results from the 7-year MammoSite registry of breast cancer patients treated with breast brachytherapy.